| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |



From the Liver Center and Department of Medicine,*
University of California, San Francisco, California; and Biogen,
Inc.,
Cambridge, Massachusetts
A prominent feature of the hepatic response to injury is production of a fetal isoform of fibronectin, a splice variant containing the EIIIA region, which appears very early after injury and derives from sinusoidal endothelial cells. Previous studies have shown that it is instrumental in initiating the cellular response to injury, specifically the conversion of resting stellate cells to myofibroblast-like cells. The present work describes the regulation of this change in fibronectin expression. Using sinusoidal endothelial cells from normal or injured liver in primary culture, we show that exogenous transforming growth factor ß (TGFß) stimulates [EIIIA]Fn expression. To assess the role of TGFß in vivo, we used a chimeric IgG containing the extracellular portion of the TGFß type II receptor as a competitive inhibitor of the cytokine. Administered to animals at the time of injury, the inhibitor reduced expression of [EIIIA]Fn mRNA by 50% as compared to controls (P < 0.01). There was a corresponding decrease in [EIIIA]Fn protein production as judged by immunohistochemistry. Cell fractionation experiments indicated that the changes observed in whole-liver extracts were localized to sinusoidal endothelial cells. We conclude that TGFß initiates wound repair in part by stimulating endothelial expression of [EIIIA]Fn. Results with the soluble inhibitor of the TGFß type II receptor suggest a novel strategy for modulating wound repair in vivo.
This article has been cited by other articles:
![]() |
S. L. Friedman Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver Physiol Rev, January 1, 2008; 88(1): 125 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Li-Korotky, P. A. Hebda, C.-Y. Lo, and J. E. Dohar Age-Dependent Differential Expression of Fibronectin Variants in Skin and Airway Mucosal Wounds Arch Otolaryngol Head Neck Surg, September 1, 2007; 133(9): 919 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Greenberg, A. M. Bernstein, M. Benezra, I. H. Gelman, L. Taliana, and S. K. Masur FAK-dependent regulation of myofibroblast differentiation FASEB J, May 1, 2006; 20(7): 1006 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Grygielko, W. M. Martin, C. Tweed, P. Thornton, J. Harling, D. P. Brooks, and N. J. Laping Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-{beta} Type I Receptor Kinase in Puromycin-Induced Nephritis J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 943 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Chang, J.-C. Chen, C. R. Alonso, A. R. Kornblihtt, and D. M. Bissell Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver PNAS, December 28, 2004; 101(52): 18093 - 18098. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Tan, Z. Sun, S. L. Opitz, T. E. Schmidt, J. H. Peters, and E. L. George Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis Blood, July 1, 2004; 104(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Klein, M. Zheng, A. Ambesi, L. Van De Water, and P. J. McKeown-Longo Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin J. Cell Sci., November 15, 2003; 116(22): 4663 - 4674. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Kunz-Schughart, S. Wenninger, T. Neumeier, P. Seidl, and R. Knuechel Three-dimensional tissue structure affects sensitivity of fibroblasts to TGF-beta 1 Am J Physiol Cell Physiol, January 1, 2003; 284(1): C209 - C219. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kim, X. Liu, H. Wang, T. Kohyama, T. Kobayashi, F.-Q. Wen, D. J. Romberger, S. Abe, W. MacNee, I. Rahman, et al. Glutathione prevents inhibition of fibroblast-mediated collagen gel contraction by cigarette smoke Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L409 - L417. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lutgens, M. Gijbels, M. Smook, P. Heeringa, P. Gotwals, V. E. Koteliansky, and M. J.A.P. Daemen Transforming Growth Factor-{beta} Mediates Balance Between Inflammation and Fibrosis During Plaque Progression Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 975 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Okamura, M. Watari, E. S. Jerud, D. W. Young, S. T. Ishizaka, J. Rose, J. C. Chow, and J. F. Strauss III The Extra Domain A of Fibronectin Activates Toll-like Receptor 4 J. Biol. Chem., March 23, 2001; 276(13): 10229 - 10233. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |